Stephen Gately

Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.

M. Stack, J. Enghild, S. Gately, 1999, The Biochemical journal.

Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.

R. Weichselbaum, V. Sukhatme, D. Kufe, 1998, Cancer research.

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

M. Stack, J. Enghild, O. Volpert, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin.

M. Stack, J. Enghild, H. Schnaper, 1996, Cancer research.

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.

E. Verrusio, H. Kwaan, Stephen Gately, 1995, The Journal of clinical investigation.